Plasma, carotene

Gollnick, H.P.M. and Siebenwirth, C., /S-Carotene plasma levels and content in oral mucosal epithelium is skin type associated, Skin Pharmacol. Appl. Skin Physiol., 15, 360, 2002. 

In addition, low plasma concentrations of vitamin C in combination with low plasma levels of p-carotene were significantly associated with an elevated risk of CVD mortality (relative risk = 1.96 95% Cl = 1.10-3.50). Results for cerebrovascular death in this study were similar, with substantially increased risks among those individuals with both low vitamin C and p-carotene plasma levels (relative risk = 4.17 95% Cl = 1.68-10.33). 

Carotenes Carotenes Plasma 156 Weighted 16 days dietary record 0.2-0.69 Bingham eta/., 1997... 

Imidazole antimycotics, ketoconazole, clotrimazole, and miconazole are potent inhibitors of various cytochrome P450-isoenzymes that also affect the metabolism of retinoids. They were fust shown to inhibit the metabolism of RA in F9 embryonal carcinoma cells. When tested in vitm liarazole, a potent CYP-inhibitor, suppressed neoplastic transformation and upregulated gap junctional communication in murine and human fibroblasts, which appeared to be due to the presence of retinoids in the serum component of the cell culture medium. Furthermore, liarazole magnified the cancer chemopreventive activity of RA and (3-carotene in these experiments by inhibiting RA-catabolism as demonstrated by absence of a decrease in RA-levels in the culture medium in the presence of liarazole over 48 h, whereas without liarazole 99% of RA was catabolized. In vivo, treatment with liarazole and ketoconazole reduced the accelerated catabolism of retinoids and increased the mean plasma all-irans-RA-concentration in patients with acute promyelocytic leukemia and other cancels. 

The mechanisms of the metabolism and excretion of P-carotene are not clear, other than the identification of a number of partially oxidised intermediates found in plasma (Khachik et al., 1992). It is assumed that the carotenoids are metabolised in a manner analogous to the P-oxidation of fatty acids although there is no evidence for this. 

It is well known that excessive intake of P-carotene may lead to carotenodermia (yellow skin), and it is undoubtedly the case that some carotenoid is directly lost via the skin or through photo-oxidation in the skin. As far as is known the carotenoids are not cytotoxic or genotoxic even at concentrations up to 10 times the normal plasma concentration which may cause carotenodermia. However, they are associated with amenorrhoea in girls who may be consuming bizarre diets and, in long-term supplementation studies, with an increase in lung cancer (The Alpha-tocopherol, Beta-carotene Cancer Prevention Study Group, 1994). 

Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells and red blood cells after long-term beta-carotene supplementation in men. Am J Clin Nutr 63(4) 553-8. 

GAMBOA-PINTO A J, ROCK C L, FERRUZZI M G, SCHOWINSKY A B and SCHWARTZ S J (1998) Cervical tissue and plasma concentrations of alpha-carotene and beta-carotene in women are correlated. /iVMtr. 128(11) 1933-6. 

Subsequent studies have confirmed that the reason for this discrepancy is that the rat is able to rapidly metabolise P-carotene to retinol in the intestine, through the action of intestinal dioxygenase. In contrast humans absorb P-carotene systemically such that plasma levels of P-carotene increase to levels not found in the rodent. A more appropriate animal model is the ferret, which shows a similar metabolism to humans. High levels of plasma P-carotene in the ferret induce the cellular transcription factors c-fos and c-jun, and squamous metaplasia is seen in the lung with or without exposure to cigarette smoke (SCF, 2000). Even after the investment of all these resources it has not been possible for the EU Scientific Committee on Food to set an ADI. 

Carotenoids and prostate cancer — Numerous epidemiological studies including prospective cohort and case-control studies have demonstrated the protective roles of lycopene, tomatoes, and tomato-derived products on prostate cancer risk other carotenoids showed no effects. " In two studies based on correlations between plasma levels or dietary intake of various carotenoids and prostate cancer risk, lycopene appeared inversely associated with prostate cancer but no association was reported for a-carotene, P-carotene, lutein, zeaxanthin, or p-cryptoxanthin. - Nevertheless, a protective role of all these carotenoids (provided by tomatoes, pumpkin, spinach, watermelon, and citrus fruits) against prostate cancer was recently reported by Jian et al. ... 

Carotenoids and breast cancer — Among seven case-control studies investigating the correlation between different carotenoid plasma levels or dietary intakes and breast cancer risk, five showed significant inverse associations with some carotenoids. - In most cases, this protective effect was due to 3-carotene and lutein. However, one (the Canadian National Breast Screening Study ) showed no association for all studied carotenoids including (I-carotene and lutein. More recently, another study even demonstrated a positive correlation between breast cancer risk and tissue and serum levels of P-carotenes and total carotenes. Nevertheless, these observational results must be confirmed by intervention studies to prove consistent. 

Carotenoids and urino-digestive cancers — On the whole, findings from epidemiological studies did not demonstrate a protective role of carotenoids against colorectal, gastric, and bladder cancers. Indeed, most prospective and case-control studies of colorectal cancer showed no association with dietary intake or plasma level of most carotenoids. - Only lycopene and lutein were shown to be protective against colorectal cancer. Otherwise, findings from the ATBC study s showed no effect of P-carotene supplementation on colorectal cancer. 

Among 27 prospective and case-control studies, 16 reported inverse associations between some carotenoids and CVDs, taking plasma or serum concentration as carotenoid biomarkers (11 of 16 studies), dietary intake (5 of 16 studies), or adipose tissue level (1 of 16 studies). With regard to the findings from the studies based on CVD risk, only two of seven presented significant inverse associations of carotenoids, particularly lycopene and P-carotene, whereas five studies of nine showed inverse correlations between myocardial infarcts and lycopene and/or P-carotene the others presented no associations. ... 

Recent findings from the ATBC stndy even showed that P-carotene snpple-mentation increased the post-trial risk of a hrst-ever non-fatal MI. Two secondary prevention trials, the Heart Protection Stndy and the ATBC presented similar resnlts. The former showed no association between P-carotene and fatal or non-fatal vascular events and the latter reported signihcantly increased risks of fatal coronary events in the P-carotene-snpplemented gronp. Resnlts of clinical trials focused on the effects of carotenoids on CVD biomarkers are controversial. Although carotenoid supplementation increased sernm levels,only lycopene was shown to be inversely associated with lipid, protein, DNA and LDL oxidation, and plasma cholesterol levels. - - ... 

Epidemiological data on carotenoids and cerebral infarcts or strokes indicate a protective effect of P-carotene and lycopene. Indeed, the Basel prospective study, the Kuopio Ischaemic Heart Disease Risk Factor study, and the Physicians Health Study " have shown an inverse correlation between carotenoid plasma level and risk of stroke. In the same way, Hirvonen et al. demonstrated, in findings from the ATBC cancer prevention stndy, an inverse association between P-carotene dietary intake and stroke. However, clinical data on carotenoids and stroke are nonexistent and they are needed to confirm this possible protective effect of carotenoids on stroke. 

Greenberg, E.R. et al.. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation, JAMA, 275, 699, 1996. 

Gey, K.F. et al.. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study, J. Clin. Invest., 71, 3, 1993. 

In contrast with the hydrocarbon carotenes primarily located in the cores of the CM particles, xanthophylls are present at the surfaces of the CM particles, making their exchanges with other plasma lipoproteins easier." Therefore, if some exchanges occur between lipoproteins, AUC (or absorption) values of the newly absorbed compound in the TRL fraction will be underestimated. Based on all these considerations, the present approach is more appropriate to determine the relative bioavailability of a compound derived from various treatments within one snbject and/or within one study. 

In fasting hnman sernm, the hydrocarbon carotenes (P-carotene and lycopene) are fonnd primarily in LDL, while the xanthophylls (Intein, zeaxanthin, and P-cryptox-anthin) are more evenly distribnted between LDLs and HDLs. As mentioned earlier and contrary to the carotenes, the xanthophylls are primarily located at the surfaces of lipoprotein particles, making them more likely to exchange between plasma lipoproteins. This hypothesis may explain their eqnal distribntion (or apparent equilibrinm) between LDLs and HDLs. 

Novotny, J.A. et al.. Plasma appearance of labeled -carotene, lutein, and retinol in humans after consumption of isotopicaUy labeled kale, J. Lipid Res., 46, 1896, 2005. 

Micozzi, M.S. et al.. Plasma carotenoid response to chronic intake of selected foods and (3-carotene supplements in men. Am. J. Clin. Nutr., 55, 1120, 1992. 

Lindqvist, A. and Andersson, S., Biochemical properties of purified recombinant human beta-carotene 15,15-monooxygenase, J. Biol. Chem., 277, 23942, 2002. Krinsky, N.I., Cornwell, D.G., and Oncley, J.I., The transport of vitamin A and carotenoids in human plasma. Arch. Biochem. Biophys., 73, 233, 1958. 

Kim, H.S. and Lee, B.M., Protective effects of antioxidant supplementation on plasma lipid peroxidation in smokers, J. Toxicol. Environ. Health A, 63, 583, 2001. Gaziano, J.M. et al.. Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation. Atherosclerosis, 112, 187, 1995. Sutherland, W.H.F. et al.. Supplementation with tomato juice increases plasma lycopene but does not alter susceptibility to oxidation of low-density lipoproteins from renal transplant recipients, Clin. Nephrol, 52, 30, 1999. 

The lag-phase measurement at 234 nm of the development of conjugated dienes on copper-stimulated LDL oxidation is used to define the oxidation resistance of different LDL samples (Esterbauer et al., 1992). During the lag phase, the antioxidants in LDL (vitamin E, carotenoids, ubiquinol-10) are consumed in a distinct sequence with a-tocopherol as the first followed by 7-tocopherol, thereafter the carotenoids cryptoxanthin, lycopene and finally /3-carotene. a-Tocopherol is the most prominent antioxidant of LDL (6.4 1.8 mol/mol LDL), whereas the concentration of the others 7-tocopherol, /3-carotene, lycopene, cryptoxanthin, zea-xanthin, lutein and phytofluene is only 1/10 to 1/300 of a-tocopherol. Since the tocopherols reside in the outer layer of the LDL molecule, protecting the monolayer of phospholipids and the carotenoids are in the inner core protecting the cholesterylesters, and the progression of oxidation is likely to occur from the aqueous interface inwards, it seems reasonable to assign to a-tocopherol the rank of the front-line antioxidant. In vivo, the LDL will also interact with the plasma water-soluble antioxidants in the circulation, not in the artery wall, as mentioned above. 

Esterbauer et al. (1991) have demonstrated that /3-carotene becomes an effective antioxidant after the depletion of vitamin E. Our studies of LDL isolated from matched rheumatoid serum and synovial fluid demonstrate a depletion of /8-carotene (Section 2.2.2.2). Oncley et al. (1952) stated that the progressive changes in the absorption spectra of LDL were correlated with the autooxidation of constituent fatty acids, the auto-oxidation being the most likely cause of carotenoid degradation. The observation that /3-carotene levels in synovial fluid LDL are lower than those of matched plasma LDL (Section 2.2.2) is interesting in that /3-carotene functions as the most effective antioxidant under conditions of low fOi (Burton and Traber, 1990). As discussed above (Section 2.1.3), the rheumatoid joint is both hypoxic and acidotic. We have also found that the concentration of vitamin E is markedly diminished in synovial fluid from inflamed joints when compared to matched plasma samples (Fairburn etal., 1992). This difference could not be accounted for by the lower concentrations of lipids and lipoproteins within synovial fluid. The low levels of both vitamin E and /3-carotene in rheumatoid synovial fluid are consistent with the consumption of lipid-soluble antioxidants within the arthritic joint due to their role in terminating the process of lipid peroxidation (Fairburn et al., 1992). 

Orlistat reduces the absorption of fat-soluble vitamins. Daily intake of a multivitamin containing vitamins A, D, E, and K, as well as 3-carotene, is recommended. Patients should take the multivitamin 2 hours prior to or after the dose of orlistat.31 Since availability of vitamin K may decline in patients receiving orlistat therapy, close monitoring of coagulation status should occur with concomitant administration of warfarin.31 Administration of orlistat in conjunction with cyclosporine can result in decreased cyclosporine plasma levels. To avoid this interaction, cyclosporine should be taken 2 hours preceding or following the dose of orlistat. Additionally, cyclosporine levels should be monitored more frequently.31... 

Carotenoids are a group of more than 750 naturally occurring molecules (Britton et al. 2004) of which about 50 occur in the normal human food chain. Of these, only 24 have, so far, been detected in human plasma and tissues (Khachik et al. 1995), with only six molecules being abundant in normal human plasma (for chemical formulas see Figure 13.1). Carotenoids are subdivided into two main classes the carotenes, cyclized (e.g., P-carotene) or uncyclized (e.g., lycopene) hydrocarbons, and the xanthophylls, which have hydroxyl groups (e.g., lutein and zeaxanthin), keto-groups (e.g., canthaxanthin), or both (e.g., astaxanthin) as functional groups. 

Interestingly, carotenoids more abundant in the blood plasma than zeaxanthin, such as lycopene, P-carotene, and P-cryptoxanthin, do not accumulate in the retina. RPE cells express p,p-carotene 15,15 -monooxygenase (BCO), formerly known as P-carotene 15,l5 -dioxygcnase, an enzyme that catalyzes the oxidative cleavage of P-carotene into two molecules of all-trans-retinal (Aleman et al., 2001 Bhatti et al., 2003 Chichili et al., 2005 Leuenberger et al., 2001 Lindqvist and Andersson, 2002). Therefore it may be suggested that p -carotene transported into RPE-cells is efficiently cleaved into retinal molecules. BCO cleaves also P-cryptoxanthin (Lindqvist and Andersson, 2002), and its absence in the retina may also be explained by its efficient cleavage to retinoids. However, lycopene, often the most abundant carotenoid in human plasma, cannot serve as a substrate for BCO, and yet it is not detectable in the neural retina (Khachik et al., 2002). 

In some studies it was shown that (3-carotene decomposes more rapidly than lutein and zeaxan-thin when exposed to oxidants or light in the presence and absence of rose bengal as a photosensitizer (Hurst et al., 2004 Ojima et al., 1993 Siems et al., 1999). However, it is not a rule, as lutein and zeaxanthin are depleted faster than (3-carotene during methylene blue photosensitized oxidation of human plasma (Ojima et al., 1993). 

---